SHIFERMAN GREGORY L. (See Remarks) received a stock award from SAGE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/21/2025ACC: 0001562180-25-000438
Officer· See Remarks
Since Nov 2024
+42K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
42K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+14K
Price / share
—
Trade value
—
% of position
70.4%
1/16/2025
19.89K→33.89K
Total
Net shares
+14K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/16/2025 | A · Award | +14K | — | — | 70.4% | 19.89K | 33.89K |
| Total | +14K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to buy)
Direct
Converts to
Common Stock
28K shares
Shares
+28K
Strike price
6.97
Held after
28K
Exercisable
—
1/16/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy) Direct | Common Stock28K shares | 1/16/2025 | A · Award | +28K | 6.97 | — | 28K |